Glossary Term:


dose-dense chemotherapy



giving the usual doses of chemo closer together (usually every 2 weeks rather than every 3-weeks). This aggressive schedule requires drugs called growth factors to be given to prevent low blood counts. This approach can lead to more side effects and be harder to take, so it is only used to treat patients who have a higher chance of the cancer coming back after treatment. See also growth factors